Amarin Announces Start of Final Clinical Site Visits in the REDUCE-IT Cardiovascular Outcomes Study
Go back to Amarin Announces Start of Final Clinical Site Visits in the REDUCE-IT Cardiovascular Outcomes Study| Amarin Corp Plc (NASDAQ: AMRN) | Delayed: 13.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.48 | 52 Week High | $3.65 | |||
| Open | $13.48 | 52 Week Low | $1.24 | |||
| Day High | $13.48 | P/E | N/A | |||
| Day Low | $13.48 | EPS | $0.00 | |||
| Volume | 50 | |||||
